Effect and safety of deep needling and shallow needling for functional constipation: A multicenter, randomized controlled trial

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e284-

  Wu, Jiani ^a   Liu, Baoyan ^a   Li, Ning ^b   Sun, Jianhua ^c   Wang, Lingling ^d   Wang, Liping ^e   Cai, Yuying ^a   Ye, Yongming ^a   Liu, Jun ^a   Wang, Yang ^a   Liu, Zhishun ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b SICHUAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; ENEMA; GLYCEROL; LACTULOSE;

ABDOMINAL DISCOMFORT; ABDOMINAL INFECTION; ABDOMINAL PAIN; ACUPUNCTURE; ACUPUNCTURE NEEDLE; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DEEP NEEDLING; DEFECATION HABIT; DEVICE INFECTION; DIARRHEA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG USE; EMERGENCY TREATMENT; FATIGUE; FECES ANALYSIS; FEMALE; FOLLOW UP; FUNCTIONAL CONSTIPATION; FUNCTIONAL DISEASE; HUMAN; INTERMETHOD COMPARISON; INTESTINAL BLEEDING; INTESTINE DISTENSION; INTESTINE FUNCTION; INTESTINE INFECTION; INTESTINE PARAMETERS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; NEEDLE PRICKING; NEEDLING; OUTCOME ASSESSMENT; PATIENT SAFETY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHALLOW NEEDLING; SINGLE BLIND PROCEDURE; SUBCUTANEOUS HEMORRHAGE; THERAPY EFFECT; TREATMENT DURATION; ADOLESCENT; CLINICAL TRIAL; DEFECATION; DEVICES; EQUIPMENT DESIGN; MIDDLE AGED; NEEDLE; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ACUPUNCTURE POINTS; ACUPUNCTURE THERAPY; ADOLESCENT; ADULT; AGED; CONSTIPATION; DEFECATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEEDLES; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920186469     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000284     Document Type: Article

References (32)

1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006; 130: 1480-1491.
2. Tack J, Muller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009; 7: 502-508quiz 496.
3. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100 (s1): S1-S4.
4. Wald A, Mueller-Lissner S, Kamm MA, et al. Survey of laxative use by adults with self-defined constipation in South America and Asia: a comparison of six countries. Aliment Pharmacol Ther. 2010; 31: 274-284.
5. Ye F, Wang QM. Epidemiology of chronic constipation in China (Chinese). Chin J Clin Healthc. 2010; 13: 665-667.
6. Du WF, Yu L, Yan XK, et al. Met-analysis on randomized controlled clinical trials of acupuncture and moxibustion on constipation (Chinese). Zhongguo Zhen Jiu. 2012; 32: 92-96.
7. Feng H, Xiang Y. Rules of selecting acupoints for constipation (Chinese). J Clin Acupuncture Moxibustion. 2003; 19: 2-3.
8. Zhang T, Chon TY, Liu B, et al. Efficacy of acupuncture for chronic constipation: a systematic review. Am J Chin Med. 2013; 41: 717-742.
9. Lin JG, Chou PC, Chu HY. An exploration of the needling depth in acupuncture: the safe needling depth and the needling depth of clinical efficacy. Evid Based Complement Alternat Med. 2013; 2013: 740508.
10. Peng WN, Wang L, Liu ZS, et al. Analysis on follow-up efficacy and safety of slow transit constipation treated with individualized deep puncture at Tianshu (ST 25): a multi-central randomized controlled trial (Chinese). Zhongguo Zhen Jiu. 2013; 33: 865-869.
11. Chen S, Li XH, Li CH, et al. Briefing on the 61st academic conference of Japanese Acupuncture Association (Chinese). Zhongguo Zhen Jiu. 2013; 33: 543-546.
12. Wang MQ. Japanese silver-needle shallow and light puncture method (Chinese). Zhongguo Zhen Jiu. 2001; 21: 615-617.
13. 64th WMA General Assembly. WMA Declaration of Helsinki- Ethical Principles for Medical Research Involving Human Subjects. 2014; http://www.wma.net/en/30publications/10policies/b3/.
14. Rome Foundation. Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. 2014; http://www.romecriteria.org/criteria/.
15. WHO Regional Office for the Western Pacific. WHO Standard Acupuncture Point Locations in the Western Pacific Region. Manila: Philippines; 2008.
16. Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010CD007570.
17. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003; 349: 1360-1368.
18. Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol. 2004; 2: 796-805.
19. The Gastrointestinal Dynamics Group of Digestive Disease Association affiliated to Chinese Medical Association, The Anus Colorectal Surgery Group of Surgery Association affiliated to Chinese Medicial Association. Diagnosis and treatment guideline of chronic constipation in China (Chinese). Chin J Gastroenterol. 2013; 18: 605-612.
20. Fritz E, Hammer HF, Lipp RW, et al. Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther. 2005; 21: 259-268.
21. Carlin A, Justham D. A literature review of two laxatives: lactulose and polyethylene glycol. Br J Community Nurs. 2011; 16: 584586, 588-590.
22. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006; 130: 1377-1390.
23. Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001; 96: 3130-3137.
24. Quigley EM, Vandeplassche L, Kerstens R, et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009; 29: 315-328.
25. Lu DW. Evaluation of therapeutic effect of deep electro-acupuncture at Tianshu (ST25) for treatment of slow transit constipation (Chinese) [Master Degree]. Nanjing, China: Nanjing University of Chinese Medicine; 2009.
26. Gordon M, Naidoo K, Akobeng AK, et al. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2012CD009118.
27. Tran LC, Di Palma JA. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol. 2005; 39: 600-602.
28. Emmanuel A, Cools M, Vandeplassche L, et al. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis. Am J Gastroenterol. 2014; 109: 887-894.
29. Ueno N, Inui A, Satoh Y. The effect of mosapride citrate on constipation in patients with diabetes. Diabetes Res Clin Pract. 2010; 87: 27-32.
30. Voskuijl W, de Lorijn F, Verwijs W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004; 53: 1590-1594.
31. Szilagyi A. Review article: lactose-a potential prebiotic. Aliment Pharmacol Ther. 2002; 16: 1591-1602.
32. Attar A, Lémann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999; 44: 226-230.